{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":7,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":7,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"21bfcc07159b","filters":{"venue":"Clinical Lymphoma"}},"results":[{"id":"W1983990351","doi":"10.3816/clm.2003.n.024","title":"Primary Adrenal Lymphoma","year":2003,"lang":"en","type":"review","venue":"Clinical Lymphoma","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Incidence (geometry); Disease; Regimen; Adrenal insufficiency; Chemotherapy; Radiation therapy; Internal medicine; Oncology; Surgery","authors":[{"name":"Andrew Grigg","is_ca":false},{"name":"Joseph M. Connors","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1218755038252844,"gpt":0.420515326986854,"spread":0.2986398231615697,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000254609,0.0008341721,0.001363015,0.002910386,0.0002180264,0.001009816,0.000556984,0.0006182952,0.005174482],"category_scores_gemma":[0.0009867789,0.0002467449,0.0003220746,0.003379817,0.0004301209,0.001292388,0.0005968917,0.0008162297,0.001675245],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006112622,"about_ca_system_score_gemma":0.0008859277,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001513685,"about_ca_topic_score_gemma":0.003560023,"domain_scores_codex":[0.9997972,0.00003470847,0.00003773228,0.00004781385,0.00005479835,0.00002777218],"domain_scores_gemma":[0.9997013,0.0001126127,0.00007373063,0.00001628348,0.00006219646,0.00003377624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"case_report","study_design_scores_codex":[0.0001019201,0.00004211602,0.002032163,0.01274369,0.000105371,0.006464309,0.00007861452,0.0002834254,0.001688185,0.0006811178,0.0430003,0.9327788],"study_design_scores_gemma":[0.0001151387,0.0001457667,0.008602371,0.00960189,0.0008969363,0.09996064,0.0003135792,0.0002232161,0.001207238,0.001336511,0.8775567,0.00004002334],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007026918,0.9951228,0.0001988004,0.0002469891,0.0002814698,0.000009187862,0.00003848728,0.00001995902,0.003379615],"genre_scores_gemma":[0.01052011,0.9857295,0.0002798238,0.0007725587,0.0005878883,0.000009948261,0.0001258482,0.000004058445,0.00197026],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005174482,"threshold_uncertainty_score":0.01731038,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2092788376","doi":"10.3816/clm.2002.s.006","title":"Acute and Long-Term Toxicities Associated with Gemtuzumab Ozogamicin (Mylotarg®) Therapy of Acute Myeloid Leukemia","year":2002,"lang":"en","type":"review","venue":"Clinical Lymphoma","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Gemtuzumab ozogamicin; Myeloid leukemia; Calicheamicin; Medicine; Leukemia; Pharmacology; Oncology; Internal medicine; CD33; Biology; Stem cell","authors":[{"name":"Lance Leopold","is_ca":true},{"name":"Mark S. Berger","is_ca":false},{"name":"Jay Feingoldr","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07021262687105202,"gpt":0.3669513961079253,"spread":0.2967387692368733,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000477603,0.0004959666,0.001484719,0.0008504753,0.0001457566,0.000453536,0.0006365299,0.0004154451,0.001605859],"category_scores_gemma":[0.000490702,0.0001516238,0.0004859994,0.001323111,0.0001692009,0.0004384082,0.00024245,0.0005040726,0.000408749],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003804608,"about_ca_system_score_gemma":0.0005638209,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008791952,"about_ca_topic_score_gemma":0.002924979,"domain_scores_codex":[0.9998672,0.00003447048,0.00002884993,0.00001892082,0.00004200292,0.000008559655],"domain_scores_gemma":[0.9997994,0.00009320495,0.00006180473,0.000004435099,0.00003119758,0.000009836207],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003161187,0.00006630861,0.0004357108,0.02571064,0.0002872946,0.0003035518,0.00004618742,0.0002521621,0.001522902,0.0004142837,0.007450509,0.9631944],"study_design_scores_gemma":[0.0005279433,0.001167203,0.01107389,0.01113598,0.003317979,0.008799763,0.0001592472,0.0002718858,0.003105483,0.0008928652,0.9595062,0.00004158183],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008408959,0.9983998,0.00009845513,0.00006772887,0.00004240872,0.000007799209,0.00002221798,0.000004454747,0.0005162068],"genre_scores_gemma":[0.003466593,0.9956424,0.0002210535,0.0001442614,0.00005062626,0.00001057721,0.00004867389,0.000001139392,0.0004146241],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001605859,"threshold_uncertainty_score":0.005372167,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2102070406","doi":"10.3816/clm.2005.n.002","title":"Origins of Waldenström's Macroglobulinemia: Does It Arise from an Unusual B-Cell Precursor?","year":2005,"lang":"en","type":"review","venue":"Clinical Lymphoma","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Canada Research Chairs","keywords":"Immunoglobulin class switching; Somatic hypermutation; Waldenstrom macroglobulinemia; Immunoglobulin D; Macroglobulinemia; B cell; Biology; Immunoglobulin M; CD40; Cytidine deaminase; Monoclonal gammopathy of undetermined significance; Immunology; Molecular biology; Antibody; Monoclonal; Genetics; Monoclonal antibody; Immunoglobulin G; Multiple myeloma; Cytotoxic T cell; Lymphoma","authors":[{"name":"Jitra Kriangkum","is_ca":true},{"name":"Brian J. Taylor","is_ca":true},{"name":"Tony Reiman","is_ca":true},{"name":"Andrew R. Belch","is_ca":true},{"name":"Linda M. Pilarski","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09611683324481807,"gpt":0.4676728339755265,"spread":0.3715560007307084,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007388284,0.0006679619,0.001552357,0.00195452,0.0002800585,0.001318949,0.001056245,0.001879937,0.001845636],"category_scores_gemma":[0.001340829,0.0003452127,0.0003789071,0.001833934,0.001041119,0.002266289,0.00064558,0.001641632,0.001022539],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007365998,"about_ca_system_score_gemma":0.001339459,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001017602,"about_ca_topic_score_gemma":0.001364853,"domain_scores_codex":[0.9998096,0.00004764461,0.00003513666,0.00003813325,0.00004484902,0.00002468152],"domain_scores_gemma":[0.9993327,0.0003760315,0.0001005747,0.00002458062,0.0001195908,0.00004644351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002093048,0.00007004891,0.003666513,0.01050095,0.0001299341,0.009157759,0.0002437752,0.0003004229,0.003170185,0.007073154,0.02500378,0.9404742],"study_design_scores_gemma":[0.00005609625,0.00007001707,0.003835701,0.004189903,0.0002331626,0.04007572,0.0003424152,0.0001003434,0.0009005966,0.00456848,0.9455935,0.00003389756],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002502025,0.9986796,0.00008093601,0.0003803779,0.0001132688,0.00000148735,0.000005218856,0.000002876428,0.0004861119],"genre_scores_gemma":[0.001903693,0.9970612,0.0001494263,0.0003186162,0.0003287678,0.000002446214,0.00001681251,0.00000105016,0.0002179932],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00195452,"threshold_uncertainty_score":0.006174266,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1974738398","doi":"10.3816/clm.2005.n.030","title":"A Randomized Phase III Study of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin as Salvage Chemotherapy Followed by Posttransplantation Rituximab Maintenance Therapy Versus Observation for Treatment of Aggressive B-Cell and T-Cell Non-Hodgkin's Lymphoma","year":2005,"lang":"en","type":"article","venue":"Clinical Lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Salvage therapy; Etoposide; Internal medicine; Oncology; Vincristine; Gemcitabine; Cytarabine; Carboplatin; Febrile neutropenia; Surgery; Chemotherapy; Rituximab; Neutropenia; Cyclophosphamide; Cisplatin; Lymphoma","authors":[{"name":"Michael Crump","is_ca":true},{"name":"Lois E. Shepherd","is_ca":true},{"name":"Boris K. Lin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04579541808009396,"gpt":0.3648090888550763,"spread":0.3190136707749824,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003234292,0.00238529,0.005769566,0.0006920897,0.0007024237,0.001756492,0.002096119,0.002523386,0.006034197],"category_scores_gemma":[0.003545253,0.001210209,0.002244413,0.0007967151,0.002922681,0.002001,0.0006738526,0.00654471,0.001530231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001709824,"about_ca_system_score_gemma":0.001899512,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001700174,"about_ca_topic_score_gemma":0.003170278,"domain_scores_codex":[0.9986112,0.0008098224,0.0000781478,0.000241634,0.00007509856,0.0001840572],"domain_scores_gemma":[0.9965588,0.001181291,0.0005450351,0.0003664668,0.0001468927,0.001201446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9882774,0.006358064,0.0001814903,0.0000967367,0.0002994596,0.00001539371,0.00002960737,0.0001556668,0.0007263187,0.00005537307,0.0001914306,0.003613074],"study_design_scores_gemma":[0.9526382,0.04602233,0.0005029665,0.000009384059,0.0002074685,0.00001427495,0.00001554728,0.000182344,0.0001479344,0.00008996664,0.0001624614,0.000007100815],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896731,0.002354844,0.0006537226,0.0007175155,0.0009940104,0.003367173,0.0006471946,0.00009566203,0.001496791],"genre_scores_gemma":[0.9866886,0.00184534,0.001740966,0.001308086,0.0008409629,0.00395129,0.0009236739,0.00004592616,0.002655166],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006034197,"threshold_uncertainty_score":0.02018642,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079316702","doi":"10.3816/clm.2005.n.010","title":"Potential Impact of a Single Nucleotide Polymorphism in the Hyaluronan Synthase 1 Gene in Waldenström's Macroglobulinemia","year":2005,"lang":"en","type":"article","venue":"Clinical Lymphoma","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"RNA splicing; Single-nucleotide polymorphism; Hyaluronan synthase; Gene; Biology; Intron; Genetics; Molecular biology; Genotype; RNA","authors":[{"name":"Sophia Adamia","is_ca":true},{"name":"Steven P. Treon","is_ca":false},{"name":"Tony Reiman","is_ca":true},{"name":"Olivier Tournilhac","is_ca":false},{"name":"Carrie McQuarrie","is_ca":true},{"name":"Michael J. Mant","is_ca":true},{"name":"Andrew R. Belch","is_ca":true},{"name":"Linda M. Pilarski","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03790136286088836,"gpt":0.3723077149982262,"spread":0.3344063521373379,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007709339,0.0005386934,0.000407234,0.001085583,0.0005329329,0.0004878206,0.0003878919,0.001116355,0.00172286],"category_scores_gemma":[0.003921777,0.0001602347,0.0004862598,0.0007379688,0.0005965121,0.0002509675,0.0002305074,0.0006274102,0.0002092503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002413899,"about_ca_system_score_gemma":0.0004097751,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001600359,"about_ca_topic_score_gemma":0.001259348,"domain_scores_codex":[0.9992513,0.0003962395,0.00006893599,0.00008459927,0.00010697,0.00009189569],"domain_scores_gemma":[0.9973042,0.001930929,0.0003025969,0.00005556897,0.0001157376,0.0002909222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005752591,0.0004901325,0.908753,0.00009166107,0.0005257687,0.02463676,0.0003323572,0.0009914102,0.0404225,0.0008284533,0.0003666263,0.01680882],"study_design_scores_gemma":[0.0002934061,0.001627311,0.9688547,0.00004046203,0.001051543,0.01522487,0.0003742015,0.003578738,0.006699775,0.001163529,0.001052523,0.0000390012],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981126,0.0006493983,0.0001657289,0.0003661508,0.00003672165,0.000004506641,0.00006986166,0.000005932235,0.0005891273],"genre_scores_gemma":[0.9995829,0.00008292287,0.00006629591,0.00006894086,0.00004196431,0.000001621312,0.00002837152,0.000001999237,0.0001249825],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00172286,"threshold_uncertainty_score":0.00576359,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2090941758","doi":"10.3816/clm.2005.n.028","title":"ABVD, the Stanford V Regimen, and BEACOPP for Hodgkin's Lymphoma: What Should an Oncologist Do?","year":2005,"lang":"en","type":"review","venue":"Clinical Lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Vincristine; Regimen; Vinblastine; Dacarbazine; Bleomycin; Prednisone; Etoposide; Internal medicine; Oncology; Hodgkin's lymphoma; Lymphoma; Chemotherapy; Cyclophosphamide","authors":[{"name":"Joseph M. Connors","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2624196302931387,"gpt":0.4975247917156729,"spread":0.2351051614225342,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007266008,0.0006064606,0.002558471,0.001308601,0.000255461,0.0007895228,0.001217093,0.001086039,0.002437184],"category_scores_gemma":[0.001059929,0.0002754826,0.0006985219,0.001899743,0.0003553107,0.001032641,0.0003588581,0.001766499,0.0009438535],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006357314,"about_ca_system_score_gemma":0.001215575,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002728191,"about_ca_topic_score_gemma":0.00825977,"domain_scores_codex":[0.9998128,0.00004481646,0.00003706832,0.00002674289,0.00006393883,0.00001477009],"domain_scores_gemma":[0.9996371,0.0001817803,0.00007017271,0.000008460921,0.00007192374,0.00003049197],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001912302,0.00005181593,0.000222613,0.0171516,0.0002263685,0.0001585375,0.00002807549,0.0002334045,0.0003211385,0.0006902597,0.04518632,0.9355386],"study_design_scores_gemma":[0.0003438574,0.000306063,0.003160167,0.01590178,0.001197263,0.002201836,0.0001252843,0.0001598807,0.0002526638,0.001477684,0.9748372,0.00003620597],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009340874,0.9990103,0.00002977754,0.0003780922,0.0001290017,0.000003119,0.00001099205,0.000003724211,0.0003415453],"genre_scores_gemma":[0.0006409282,0.9984218,0.0001190599,0.000448095,0.000125879,0.000004314203,0.00002412358,9.107436e-7,0.0002149706],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002728191,"threshold_uncertainty_score":0.008153141,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1994225339","doi":"10.3816/clm.2003.n.019","title":"Lymphomas and Oncolytic Virus Therapy","year":2003,"lang":"en","type":"review","venue":"Clinical Lymphoma","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Blood Services; Calgary Laboratory Services; University of Alberta; University of Calgary","funders":"","keywords":"Oncolytic virus; Viral therapy; Virology; Lymphoma; Virus; Cancer therapy; Medicine; Cancer; Immunology; Coronavirus disease 2019 (COVID-19); Internal medicine; Disease; Infectious disease (medical specialty)","authors":[{"name":"Tommy Alain","is_ca":true},{"name":"Chandini M. Thirukkumaran","is_ca":true},{"name":"Donald G. Morris","is_ca":true},{"name":"Stefan J. Urbanski","is_ca":true},{"name":"Anna Janowska‐Wieczorek","is_ca":true},{"name":"Patrick W.K. Lee","is_ca":true},{"name":"Anna E. Kossakowska","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1193231851807176,"gpt":0.4431997913370223,"spread":0.3238766061563046,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009327236,0.001214946,0.001625021,0.002219372,0.0003739182,0.001303177,0.001245118,0.001811538,0.002831127],"category_scores_gemma":[0.0007431213,0.0003635053,0.0004179386,0.0023833,0.0008727857,0.001480941,0.0006611834,0.003072989,0.002483157],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001344823,"about_ca_system_score_gemma":0.001150013,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00155314,"about_ca_topic_score_gemma":0.003143057,"domain_scores_codex":[0.9998068,0.00003975557,0.00001949851,0.00003053018,0.00007850049,0.00002486319],"domain_scores_gemma":[0.9997616,0.0001207679,0.00002402436,0.00001138263,0.00005976399,0.00002242163],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001605377,0.0001344686,0.0001263951,0.005177781,0.00005295988,0.0004057766,0.00005104558,0.0006765327,0.003096343,0.007598719,0.05827723,0.9242422],"study_design_scores_gemma":[0.00004675461,0.00005765874,0.0001738232,0.0008289769,0.000046915,0.00107093,0.00002543806,0.0000998449,0.0007489771,0.001771814,0.9951192,0.000009825528],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009253256,0.9970362,0.0003646069,0.0003106853,0.0005195923,0.000007761307,0.00001045734,0.00001408112,0.001644203],"genre_scores_gemma":[0.0009037672,0.9956807,0.0004820011,0.0004207548,0.0003742099,0.00001895605,0.00003305978,0.000003705832,0.002082809],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002831127,"threshold_uncertainty_score":0.009757459,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}